Skyrocketing demands for medical oxygen dominated headlines during the worst of the pandemic. With low and middle income countries (LMICs) seemingly hardest-hit, question marks were raised over the global preparedness – or lack thereof – of the medical gases industry.
Vital for treating the potentially devastating impact that Covid-19 can have on the respiratory system, oxygen is considered by frontline aid agency Medicin sans Frontieres to be ‘the single most important’ medicine for treating Covid-19. With the pandemic threatening global supply chains, the prospect of generating oxygen onsite using air separation units (ASUs) and pressure-swing adsorption (PSA) systems presented an opportunity to revolutionise medical oxygen delivery.
Taking advantage of this opportunity, oxygen generation specialist Novair has taken steps to maximise its oxygen supply potential. Commenting on the moves being made by Novair was the company’s President Bernard Zenou, who spoke with gasworld during the Medical Gases Virtual Event 2022.
“From the beginning, oxygen therapy has been the only available therapy to treat patients affected by Covid-19,” he began.
... to continue reading you must be subscribed
